249
Views
0
CrossRef citations to date
0
Altmetric
Studies in humans

The longitudinal associations between sweet potato intake and the risk of non-alcoholic fatty liver disease: the TCLSIH cohort study

, , , , , , , , , , , , , , , , , , , , , , , & show all
Pages 809-820 | Received 11 Jan 2022, Accepted 05 Mar 2022, Published online: 09 Apr 2022

References

  • Abenavoli L, Larussa T, Corea A, Procopio AC, Boccuto L, Dallio M, Federico A, Luzza F. 2021. Dietary polyphenols and non-alcoholic fatty liver disease. Nutrients. 13(2):494.
  • Ahn J, Lee H, Jung CH, Ha T. 2012. Lycopene inhibits hepatic steatosis via microRNA-21-induced downregulation of fatty acid-binding protein 7 in mice fed a high-fat diet. Mol Nutr Food Res. 56(11):1665–1674.
  • Bach D, Bedin AC, Lacerda LG, Nogueira A, Demiate IM. 2021. Sweet potato (Ipomoea batatas L.): a versatile raw material for the food industry. Braz Arch Biol Technol. 64(4):14.
  • Ballestri S, Nascimbeni F, Baldelli E, Marrazzo A, Romagnoli D, Lonardo A. 2017. NAFLD as a sexual dimorphic disease: role of gender and reproductive status in the development and progression of nonalcoholic fatty liver disease and inherent cardiovascular risk. Adv Ther. 34(6):1291–1326.
  • Bellentani S, Scaglioni F, Marino M, Bedogni G. 2010. Epidemiology of non-alcoholic fatty liver disease. Dig Dis. 28(1):155–161.
  • Bindels LB, Walter J, Ramer-Tait AE. 2015. Resistant starches for the management of metabolic diseases. Curr Opin Clin Nutr Metab Care. 18(6):559–565.
  • Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, Harrison SA, Brunt EM, Sanyal AJ. 2018. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 67(1):328–357.
  • Christensen K, Lawler T, Mares J. 2019. Dietary carotenoids and non-alcoholic fatty liver disease among uS Adults, NHANES 2003(-)2014. Nutrients. 11(5):1101.
  • Craig CL, Marshall AL, Sjostrom M, Bauman AE, Booth ML, Ainsworth BE, Pratt M, Ekelund U, Yngve A, Sallis JF, et al. 2003. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 35(8):1381–1395.
  • De Silva NMG, Borges MC, Hingorani AD, Engmann J, Shah T, Zhang X, Luan J, Langenberg C, Wong A, Kuh D, et al. 2019. Liver function and risk of type 2 diabetes: bidirectional mendelian randomization study. Diabetes. 68(8):1681–1691.
  • DiStefano JK. 2020. NAFLD and NASH in postmenopausal women: implications for diagnosis and treatment. Endocrinology. 161(10):bqaa134.
  • Esposito E, Iacono A, Bianco G, Autore G, Cuzzocrea S, Vajro P, Canani RB, Calignano A, Raso GM, Meli R. 2009. Probiotics reduce the inflammatory response induced by a high-fat diet in the liver of young rats. J Nutr. 139(5):905–911.
  • Farrell GC, Chitturi S, Lau GK, Sollano JD, Asia P, Working Party On N. 2007. Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region: executive summary. J Gastroenterol Hepatol. 22(6):775–777.
  • Gu Y, Li H, Bao X, Zhang Q, Liu L, Meng G, Wu H, Du H, Shi H, Xia Y, et al. 2017. The relationship between thyroid function and the prevalence of type 2 diabetes mellitus in euthyroid subjects. J Clin Endocrinol Metab. 102(2):434–442.
  • Keenan MJ, Zhou J, Hegsted M, Pelkman C, Durham HA, Coulon DB, Martin RJ. 2015. Role of resistant starch in improving gut health, adiposity, and insulin resistance. Adv Nutr. 6(2):198–205.
  • Kiefer I, Rathmanner T, Kunze M. 2005. Eating and dieting differences in men and women. J Mens Health Gender. 2(2):194–201.
  • Koplay M, Sivri M, Erdogan H, Nayman A. 2015. Importance of imaging and recent developments in diagnosis of nonalcoholic fatty liver disease. World J Hepatol. 7(5):769–776.
  • Kurata R, Sun HN, Oki T, Okuno S, Sugawara T. 2019. Sweet potato: chemistry, processing, and nutrition. 1st ed. London: Academic Press.
  • Lazo M, Hernaez R, Eberhardt MS, Bonekamp S, Kamel I, Guallar E, Koteish A, Brancati FL, Clark JM. 2013. Prevalence of nonalcoholic fatty liver disease in the United States: the third national health and nutrition examination survey, 1988-1994. Am J Epidemiol. 178(1):38–45.
  • Ludvik B, Hanefeld M, Pacini G. 2008. Improved metabolic control by Ipomoea batatas (Caiapo) is associated with increased adiponectin and decreased fibrinogen levels in type 2 diabetic subjects. Diabetes Obes Metab. 10(7):586–592.
  • Ludvik B, Waldhausl W, Prager R, Kautzky-Willer A, Pacini G. 2003. Mode of action of ipomoea batatas (Caiapo) in type 2 diabetic patients. Metabolism. 52(7):875–880.
  • Mariano RDA, Thatyane Sampaio KB, Evandro LDS. 2019. Sweet potato roots: unrevealing an old food as a source of health promoting bioactive compounds – a review. Trends Food Sci Technol. 85:277–286.
  • McKay A, Wilman HR, Dennis A, Kelly M, Gyngell ML, Neubauer S, Bell JD, Banerjee R, Thomas EL. 2018. Measurement of liver iron by magnetic resonance imaging in the UK Biobank population. PLOS One. 13(12):e0209340.
  • Mohanraj R, Sivasankar S. 2014. Sweet potato (Ipomoea batatas [L.] Lam)-a valuable medicinal food: a review . J Med Food. 17(7):733–741.
  • Mundi MS, Velapati S, Patel J, Kellogg TA, Abu Dayyeh BK, Hurt RT. 2020. Evolution of NAFLD and its management. Nutr Clin Pract. 35(1):72–84.
  • Naowaboot J, Piyabhan P, Munkong N, Parklak W, Pannangpetch P. 2016. Ferulic acid improves lipid and glucose homeostasis in high-fat diet-induced obese mice. Clin Exp Pharmacol Physiol. 43(2):242–250.
  • Nielsen S, Guo Z, Johnson CM, Hensrud DD, Jensen MD. 2004. Splanchnic lipolysis in human obesity. J Clin Invest. 113(11):1582–1588.
  • Oki T, Kano M, Ishikawa F, Goto K, Watanabe O, Suda I. 2017. Double-blind, placebo-controlled pilot trial of anthocyanin-rich purple sweet potato beverage on serum hepatic biomarker levels in healthy Caucasians with borderline hepatitis. Eur J Clin Nutr. 71(2):290–292.
  • Ozaki S, Oki N, Suzuki S, Kitamura S. 2010. Structural characterization and hypoglycemic effects of arabinogalactan-protein from the tuberous cortex of the white-skinned sweet potato (Ipomoea batatas L.). J Agric Food Chem. 58(22):11593–11599.
  • Panchal SK, Ward L, Brown L. 2013. Ellagic acid attenuates high-carbohydrate, high-fat diet-induced metabolic syndrome in rats. Eur J Nutr. 52(2):559–568.
  • Perez-Montes de Oca A, Julian MT, Ramos A, Puig-Domingo M, Alonso N. 2020. Microbiota, fiber, and NAFLD: is there any connection? Nutrients. 12(10):3100.
  • Saadeh S, Younossi ZM, Remer EM, Gramlich T, Ong JP, Hurley M, Mullen KD, Cooper JN, Sheridan MJ. 2002. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology. 123(3):745–750.
  • Salomone F, Ivancovsky-Wajcman D, Fliss-Isakov N, Webb M, Grosso G, Godos J, Galvano F, Shibolet O, Kariv R, Zelber-Sagi S. 2020. Higher phenolic acid intake independently associates with lower prevalence of insulin resistance and non-alcoholic fatty liver disease. JHEP Rep. 2(2):100069.
  • Senanayake SA, Ranaweera KK, Gunaratne A, Bamunuarachchi A. 2013. Comparative analysis of nutritional quality of five different cultivars of sweet potatoes (Ipomea batatas (L) Lam) in Sri Lanka. Food Sci Nutr. 1(4):284–291.
  • Shih CK, Chen CM, Hsiao TJ, Liu CW, Li SC. 2019. White sweet potato as meal replacement for overweight white-collar workers: a randomized controlled trial. Nutrients. 11(1):165.
  • Suda I, Ishikawa F, Hatakeyama M, Miyawaki M, Kudo T, Hirano K, Ito A, Yamakawa O, Horiuchi S. 2008. Intake of purple sweet potato beverage affects on serum hepatic biomarker levels of healthy adult men with borderline hepatitis. Eur J Clin Nutr. 62(1):60–67.
  • Sun J, Zhou B, Tang C, Gou Y, Chen H, Wang Y, Jin C, Liu J, Niu F, Kan J, et al. 2018. Characterization, antioxidant activity and hepatoprotective effect of purple sweetpotato polysaccharides. Int J Biol Macromol. 115:69–76.
  • Harazaki T, Inoue S, Imai C, Mochizuki K, Goda T. 2014. Resistant starch improves insulin resistance and reduces adipose tissue weight and CD11c expression in rat OLETF adipose tissue. Nutrition. 30(5):590–595.
  • Wang S, Nie S, Zhu F. 2016. Chemical constituents and health effects of sweet potato. Food Res Int. 89(Pt 1):90–116.
  • Wang X, Zhang ZF, Zheng GH, Wang AM, Sun CH, Qin SP, Zhuang J, Lu J, Ma DF, Zheng YL. 2017. Attenuation of hepatic steatosis by purple sweet potato colour is associated with blocking Src/ERK/C/EBPβ signalling in high-fat-diet-treated mice. Appl Physiol Nutr Metab. 42(10):1082–1091.
  • Willett WC, Howe GR, Kushi LH. 1997. Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr. 65(4 Suppl):1220S–1228S. discussion 1229S-1231S.
  • Xia Y, Lu Z, Lu M, Liu M, Liu L, Meng G, Yu B, Wu H, Bao X, Gu Y, et al. 2019. Raw orange intake is associated with higher prevalence of non-alcoholic fatty liver disease in an adult population. Nutrition. 60:252–260.
  • Yang YX. 2009. Chinese food consumption tables. 2nd ed. Beijing: Peking University Medical Press.
  • Ye H, Li Q, Zhang Z, Sun M, Zhao C, Zhang T. 2017. Effect of a novel potential probiotic Lactobacillus paracasei Jlus66 isolated from fermented milk on nonalcoholic fatty liver in rats. Food Funct. 8(12):4539–4546.
  • Ye Q, Zou B, Yeo YH, Li J, Huang DQ, Wu Y, Yang H, Liu C, Kam LY, Tan XXE, et al. 2020. Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 5(8):739–752.
  • Younossi ZM. 2019. Non-alcoholic fatty liver disease – a global public health perspective. J Hepatol. 70(3):531–544.
  • Younossi ZM, Marchesini G, Pinto-Cortez H, Petta S. 2019. Epidemiology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: implications for liver transplantation. Transplantation. 103(1):22–27.
  • Zhang S, Fu J, Zhang Q, Liu L, Meng G, Yao Z, Wu H, Bao X, Gu Y, Lu M, et al. 2019. Association between nut consumption and non-alcoholic fatty liver disease in adults. Liver Int. 39(9):1732–1741.
  • Zhou F, Zhou J, Wang W, Zhang XJ, Ji YX, Zhang P, She ZG, Zhu L, Cai J, Li H. 2019. Unexpected rapid increase in the Burden of NAFLD in China from 2008 to 2018: a systematic review and meta-analysis. Hepatology. 70(4):1119–1133.
  • Zhu X, Lin X, Zhang P, Liu Y, Ling W, Guo H. 2022. Upregulated NLRP3 inflammasome activation is attenuated by anthocyanins in patients with nonalcoholic fatty liver disease: a case-control and an intervention study. Clin Res Hepatol Gastroenterol. 46(4):101843.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.